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Abstract - The first line approach for subclavian steal 
syndrome is PTA-stenting of subclavian artery. When 
the ipsilateral vertebral artery origin is involved or in 
closed proximity of the atherosclerotic lesion in the 
subclavian artery PTA-stenting is at risk of ipsilateral 
vertebral artery coverage. Herein we report our 
experience with DEB to address lesions involving the 
subclavian artery and the origin of the ipsilateral 
vertebral artery. From January 2017 to February 2019, 
patients presenting subclavian artery lesion involving 
the origin of the ipsilateral vertebral artery and treated 
using primary DEB, were included. Three patients, 
with left subclavian steal syndrome, were identified. 
The perioperative mortality and morbidity were 
outcomes evaluated. Freedom from occlusion, 
secondary patency, amputation rate was registered. A 
total of 3 (2 female) patients were included in the 
study. No complication, symptoms recurrence, 
restenosis or occlusion were reported at duplex scan 
during 12-month follow-up. Indication for stenting 
was arterial dissection. In our limited experience, the 
use of DEB in association to embolic protection 
device in the treatment of atherosclerotic subclavian 
lesion involving the origin of the vertebral artery was 
safe and technically feasible. 
 
Keywords: subclavian artery stenosis, balloon 




The first line approach of subclavian steal syndrome 
is PTA-stenting of subclavian artery. When the 
ipsilateral vertebral artery origin is involved or close 
to the atherosclerotic lesion in the subclavian artery, 
PTA-stenting is at risk of ipsilateral vertebral artery 
coverage: in this case, the open surgical treatment is 
indicated. However, applying the knowledge gained 
by use of Drug eluting balloon (DEB) in peripheral 
artery disease, we think it’s possible to extend the 
endovascular treatment also in vertebral artery 
involving cases. Herein we report our experience with 
DEB to treat lesions involving the subclavian artery 




A retrospective analysis of patients with subclavian 
steal syndrome, addressed with endovascular 
procedures, was conducted. From January 2017 to 
February 2019, were included patients presenting 
subclavian artery lesion involving the origin of the 
ipsilateral vertebral artery and treated using primary 
DEB (Fig. 1). Three patients with left subclavian steal 
syndrome, were identified. All cases were treated with 
a percutaneous transfemoral approach, using an 
embolic protection device located in ipsilateral 
vertebral artery (Fig. 2). The outcomes evaluated were 
perioperative mortality and morbidity. Freedom from 
occlusion, secondary patency, amputation rate was 
registered. Addition maneuvers including stenting or 






Figure 1. Left subclavian artery stenosis, in patient with 
subclavian steal syndrome.  
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Figure 2. Embolic protection device deployed inside the 










A total of 3 (2 female) patients with a mean age of 66 
years were included in the study. Technical success 
was achieved in all cases (Fig. 3). After the 
angioplasty using DEB, an additional stenting 
procedure was required in one case because of a 
proximal dissection: the origin of ipsilateral vertebral 
artery was not covered during stent released. At end 
of procedure, all patients recovered from the 
preoperative clinical condition. No complication, 
symptoms recurrence, restenosis or occlusion were 
reported at duplex scan during 12-month follow-up. 




Traditional open surgical revascularization treatments 
have shown excellent long-term durability for supra-
aortic vessels. Neurological manifestations such as 
dizziness, visual disturbances, and stroke indicate 
failure perfusion of the central nervous system, which 
is a significant predictor of mortality1. However, the 
risk of stroke and TIA recurrence in symptomatic 
patients may be three times higher compared with 
patients without stenosis2. Endovascular treatment is 
the first therapeutic option for subclavian artery 
occlusive lesions, and generally provides positive 
results3. In literature, there are few cases of 
endovascular treatment in still syndrome vertebral 
artery involving. Maciejewski et al. reports an 
experience of simultaneous vertebral and subclavian 
artery stenting with good outcome in terms of patency 
and procedure success rates using DEB for cases of 
intrastent restenosis4. The experience with DEB in 
peripheral artery disease has showed a reduction of 
the number of stents and often of their length after 
PTA5. Thus, we think that DEB can be an efficient and 




In our limited experience, the use of DEB in 
association to embolic protection device in the 
treatment of atherosclerotic subclavian lesion 
involving the origin of the vertebral artery was safe 
and technically feasible. The use of DEB represents 
an additional tool for patients with complex 
subclavian lesions involving the vertebral artery 
origin that are unfit for conventional surgery or when 
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